source
- Argenx to acquire Unnatural Products in deal worth up to $1.15BArgenx said Monday it will buy a macrocycle biotech that started out of a garage in a deal totaling up to about $1.15 billion. Argenx will pay $550 million upfront in cash with as much ...Endpoints · 38m ago↗ source
- Vir Biotechnology reports positive results for hepatitis D combo in first pivotal trialVir Biotechnology announced that its chronic hepatitis D treatment met its primary goal in the first of three late‑stage studies. The trial evaluated a once‑monthly combination therapy that include…